Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease

Acetylcholinesterase (AChE) plays an important role in Alzheimer's disease (AD). The excessive activity of AChE causes various neuronal problems, particularly dementia and neuronal cell deaths. Generally, anti-AChE drugs induce some serious neuronal side effects in humans. Therefore, this study...

Full description

Bibliographic Details
Main Authors: Subramaniyan Vijayakumar, Palani Manogar, Srinivasan Prabhu, Ram Avadhar Sanjeevkumar Singh
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Journal of Pharmaceutical Analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177917300941
id doaj-0169a824c1da4cb9890a64ce1046e550
record_format Article
spelling doaj-0169a824c1da4cb9890a64ce1046e5502021-04-02T10:34:49ZengElsevierJournal of Pharmaceutical Analysis2095-17792018-12-0186413420Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's diseaseSubramaniyan Vijayakumar0Palani Manogar1Srinivasan Prabhu2Ram Avadhar Sanjeevkumar Singh3Computational Phytochemistry Laboratory, PG and Research Department of Botany and Microbiology, AVVM Sri Pushpam College (Autonomous) Poondi, Thanjavur (Dist), Tamil Nadu, India; Corresponding author.Computational Phytochemistry Laboratory, PG and Research Department of Botany and Microbiology, AVVM Sri Pushpam College (Autonomous) Poondi, Thanjavur (Dist), Tamil Nadu, IndiaComputational Phytochemistry Laboratory, PG and Research Department of Botany and Microbiology, AVVM Sri Pushpam College (Autonomous) Poondi, Thanjavur (Dist), Tamil Nadu, IndiaComputer Aided Drug Design and Molecular Modeling Laboratory, Department of Bioinformatics, Alagappa University, Karaikudi 630004, Tamil Nadu, IndiaAcetylcholinesterase (AChE) plays an important role in Alzheimer's disease (AD). The excessive activity of AChE causes various neuronal problems, particularly dementia and neuronal cell deaths. Generally, anti-AChE drugs induce some serious neuronal side effects in humans. Therefore, this study sought to identify alternative drug molecules from natural products with fewer side effects than those of conventional drugs for treating AD. To achieve this, we developed computational methods for predicting drug and target binding affinities using the Schrodinger suite. The target and ligand molecules were retrieved from established databases. The target enzyme has 539 amino acid residues in its sequence alignment. Ligand molecules of 20 bioactive molecules were obtained from different kinds of plants, after which we performed critical analyses such as molecular docking; molecular dynamic (MD) simulations; and absorption, distribution, metabolism, and excretion (ADME) analysis. In the docking studies, the natural compound rutin showed a superior docking score of −12.335 with a good binding energy value of −73.313 kcal/mol. Based on these findings, rutin and the target complex was used to perform MD simulations to analyze rutin stability at 30 ns. In conclusion, our study demonstrates that rutin is a superior drug candidate for AD. Therefore, we propose that this molecule is worth further investigation using in vitro studies. Keywords: Alzheimer's disease, Acetylcholinesterase, Phytocompounds, Molecular docking, Free energy calculations, Molecular dynamic simulationshttp://www.sciencedirect.com/science/article/pii/S2095177917300941
collection DOAJ
language English
format Article
sources DOAJ
author Subramaniyan Vijayakumar
Palani Manogar
Srinivasan Prabhu
Ram Avadhar Sanjeevkumar Singh
spellingShingle Subramaniyan Vijayakumar
Palani Manogar
Srinivasan Prabhu
Ram Avadhar Sanjeevkumar Singh
Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease
Journal of Pharmaceutical Analysis
author_facet Subramaniyan Vijayakumar
Palani Manogar
Srinivasan Prabhu
Ram Avadhar Sanjeevkumar Singh
author_sort Subramaniyan Vijayakumar
title Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease
title_short Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease
title_full Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease
title_fullStr Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease
title_full_unstemmed Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease
title_sort novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for alzheimer's disease
publisher Elsevier
series Journal of Pharmaceutical Analysis
issn 2095-1779
publishDate 2018-12-01
description Acetylcholinesterase (AChE) plays an important role in Alzheimer's disease (AD). The excessive activity of AChE causes various neuronal problems, particularly dementia and neuronal cell deaths. Generally, anti-AChE drugs induce some serious neuronal side effects in humans. Therefore, this study sought to identify alternative drug molecules from natural products with fewer side effects than those of conventional drugs for treating AD. To achieve this, we developed computational methods for predicting drug and target binding affinities using the Schrodinger suite. The target and ligand molecules were retrieved from established databases. The target enzyme has 539 amino acid residues in its sequence alignment. Ligand molecules of 20 bioactive molecules were obtained from different kinds of plants, after which we performed critical analyses such as molecular docking; molecular dynamic (MD) simulations; and absorption, distribution, metabolism, and excretion (ADME) analysis. In the docking studies, the natural compound rutin showed a superior docking score of −12.335 with a good binding energy value of −73.313 kcal/mol. Based on these findings, rutin and the target complex was used to perform MD simulations to analyze rutin stability at 30 ns. In conclusion, our study demonstrates that rutin is a superior drug candidate for AD. Therefore, we propose that this molecule is worth further investigation using in vitro studies. Keywords: Alzheimer's disease, Acetylcholinesterase, Phytocompounds, Molecular docking, Free energy calculations, Molecular dynamic simulations
url http://www.sciencedirect.com/science/article/pii/S2095177917300941
work_keys_str_mv AT subramaniyanvijayakumar novelligandbaseddockingmoleculardynamicsimulationsandabsorptiondistributionmetabolismandexcretionapproachtoanalyzingpotentialacetylcholinesteraseinhibitorsforalzheimersdisease
AT palanimanogar novelligandbaseddockingmoleculardynamicsimulationsandabsorptiondistributionmetabolismandexcretionapproachtoanalyzingpotentialacetylcholinesteraseinhibitorsforalzheimersdisease
AT srinivasanprabhu novelligandbaseddockingmoleculardynamicsimulationsandabsorptiondistributionmetabolismandexcretionapproachtoanalyzingpotentialacetylcholinesteraseinhibitorsforalzheimersdisease
AT ramavadharsanjeevkumarsingh novelligandbaseddockingmoleculardynamicsimulationsandabsorptiondistributionmetabolismandexcretionapproachtoanalyzingpotentialacetylcholinesteraseinhibitorsforalzheimersdisease
_version_ 1724167090069307392